Notably, patients with a higher expression of PD-L1 and CD8+ had better survival compared to those with a lower expression of PD-L1 and CD8+, indicating that PD-L1 and CD8+ cytotoxic T cells may promote the eradication of HCC. Here, CD8A is linked to hepatocellular carcinoma.